NRIX
NRIX
US67080M1036
Nurix Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 83.980.000 54.549.000
54.0%
Cost of Revenue -- --
--
Gross Profit -- --
--
369.646.000 267.576.000
38.1%
Operating Income -285.666.000 -213.027.000
34.1%
Pretax Income -263.697.000 -193.299.000
36.4%
Net Income Common Stockholders -264.457.000 -193.569.000
36.6%
-- --
--
-- --
--
ende